A uveíte pode afetar indivíduos de qualquer idade ou sexo.[3]Burkholder BM, Jabs DA. Uveitis for the non-ophthalmologist. BMJ. 2021 Feb 3;372:m4979.
http://www.ncbi.nlm.nih.gov/pubmed/33536186?tool=bestpractice.com
Nos EUA, estudos populacionais e de registro sugerem uma incidência de uveíte de 24.9 a 112.84 por 100,000 pessoas-ano.[4]Acharya NR, Tham VM, Esterberg E, et al. Incidence and prevalence of uveitis: results from the Pacific Ocular Inflammation Study. JAMA Ophthalmol. 2013 Nov;131(11):1405-12.
https://jamanetwork.com/journals/jamaophthalmology/fullarticle/1735103
http://www.ncbi.nlm.nih.gov/pubmed/24008391?tool=bestpractice.com
[5]Gritz DG, Wong IG. Incidence and prevalence of uveitis in Northern California; the Northern California Epidemiology of Uveitis Study. Ophthalmology. 2004 Mar;111(3):491-500.
http://www.ncbi.nlm.nih.gov/pubmed/15019324?tool=bestpractice.com
[6]Kung TP, Hunt MS, McKay M, et al. Uveitis incidence in the United States (US): a database study using the Intelligent Research in Sight (IRIS)® registry. IOVS. 2021 Jun;62(8):1404.
https://iovs.arvojournals.org/article.aspx?articleid=2773266
[7]Suhler EB, Lloyd MJ, Choi D, et al. Incidence and prevalence of uveitis in veterans affairs medical centers of the Pacific Northwest. Am J Ophthalmol. 2008 Dec;146(6):890-6.e8.
http://www.ncbi.nlm.nih.gov/pubmed/19027424?tool=bestpractice.com
A prevalência estimada nos EUA é de 115.3 a 540 por 100,000.[5]Gritz DG, Wong IG. Incidence and prevalence of uveitis in Northern California; the Northern California Epidemiology of Uveitis Study. Ophthalmology. 2004 Mar;111(3):491-500.
http://www.ncbi.nlm.nih.gov/pubmed/15019324?tool=bestpractice.com
[8]González MM, Solano MM, Porco TC, et al. Epidemiology of uveitis in a US population-based study. J Ophthalmic Inflamm Infect. 2018 Apr 17;8(1):6.
https://pmc.ncbi.nlm.nih.gov/articles/PMC5904090
http://www.ncbi.nlm.nih.gov/pubmed/29666980?tool=bestpractice.com
A idade média no diagnóstico nos EUA é de 53 anos.[8]González MM, Solano MM, Porco TC, et al. Epidemiology of uveitis in a US population-based study. J Ophthalmic Inflamm Infect. 2018 Apr 17;8(1):6.
https://pmc.ncbi.nlm.nih.gov/articles/PMC5904090
http://www.ncbi.nlm.nih.gov/pubmed/29666980?tool=bestpractice.com
[9]Amin S, Seabury SA, Rao MA, et al. Measuring the incidence and prevalence of uveitis and scleritis in a national medical claims database. 2019 Jul;60(9):6658.
https://iovs.arvojournals.org/article.aspx?articleid=2745599
A uveíte afeta mais comumente pessoas entre 20 e 60 anos.[10]Abdulaal MR, Abiad BH, Hamam RN. Uveitis in the aging eye: incidence, patterns, and differential diagnosis. J Ophthalmol. 2015;2015:509456.
https://pmc.ncbi.nlm.nih.gov/articles/PMC4452188
http://www.ncbi.nlm.nih.gov/pubmed/26090218?tool=bestpractice.com
[11]Barisani-Asenbauer T, Maca SM, Mejdoubi L, et al. Uveitis: a rare disease often associated with systemic diseases and infections - a systematic review of 2619 patients. Orphanet J Rare Dis. 2012 Aug 29;7:57.
https://ojrd.biomedcentral.com/articles/10.1186/1750-1172-7-57
http://www.ncbi.nlm.nih.gov/pubmed/22932001?tool=bestpractice.com
A uveíte anterior é a forma mais comum, sendo responsável por pelo menos metade dos casos de uveíte nos países ocidentais em uma revisão.[12]Miserocchi E, Fogliato G, Modorati G, et al. Review on the worldwide epidemiology of uveitis. Eur J Ophthalmol. 2013 Sep-Oct;23(5):705-17.
http://www.ncbi.nlm.nih.gov/pubmed/23661536?tool=bestpractice.com
A uveíte posterior é menos comum, seguida pela uveíte intermediária.[11]Barisani-Asenbauer T, Maca SM, Mejdoubi L, et al. Uveitis: a rare disease often associated with systemic diseases and infections - a systematic review of 2619 patients. Orphanet J Rare Dis. 2012 Aug 29;7:57.
https://ojrd.biomedcentral.com/articles/10.1186/1750-1172-7-57
http://www.ncbi.nlm.nih.gov/pubmed/22932001?tool=bestpractice.com
[12]Miserocchi E, Fogliato G, Modorati G, et al. Review on the worldwide epidemiology of uveitis. Eur J Ophthalmol. 2013 Sep-Oct;23(5):705-17.
http://www.ncbi.nlm.nih.gov/pubmed/23661536?tool=bestpractice.com
A uveíte infecciosa é comum (30% a 60% dos casos) nos países em desenvolvimento.[13]Tsirouki T, Dastiridou A, Symeonidis C, et al. A focus on the epidemiology of uveitis. Ocul Immunol Inflamm. 2018;26(1):2-16.
http://www.ncbi.nlm.nih.gov/pubmed/27467180?tool=bestpractice.com
A uveíte não infecciosa é mais comum em países desenvolvidos.[12]Miserocchi E, Fogliato G, Modorati G, et al. Review on the worldwide epidemiology of uveitis. Eur J Ophthalmol. 2013 Sep-Oct;23(5):705-17.
http://www.ncbi.nlm.nih.gov/pubmed/23661536?tool=bestpractice.com